Français
ItalianoBond Teva Pharmaceutical Industries 0.25% ( US88163VAE92 ) in USD
| Issuer | Teva Pharmaceutical Industries | ||||||||||||||||||||||||||||||
| Market price | 97.004 % ▲ | ||||||||||||||||||||||||||||||
| Country |  Israel
|
||||||||||||||||||||||||||||||
| ISIN code |
 US88163VAE92 ( in USD )
|
||||||||||||||||||||||||||||||
| Interest rate | 0.25% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||
| Maturity | 02/01/2026 - Bond has expired | ||||||||||||||||||||||||||||||
| Minimal amount | 1 000 USD | ||||||||||||||||||||||||||||||
| Total amount | 575 000 000 USD | ||||||||||||||||||||||||||||||
| Cusip | 88163VAE9 | ||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BB+ ( Non-investment grade speculative ) | ||||||||||||||||||||||||||||||
| Moody's rating | Ba1 ( Non-investment grade speculative ) | ||||||||||||||||||||||||||||||
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. Teva Pharmaceutical Industries (ISIN: US88163VAE92, CUSIP: 88163VAE9) issued a USD 575,000,000 bond (maturity date 01/02/2026, coupon rate 0.25%, minimum purchase 1000) currently trading at 97% of par, with a semi-annual coupon payment, rated BB by S&P and Ba2 by Moody's. |
||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||